Gemina Laboratories (XCNQ:GLAB) Accounts Payable : C$1.67 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Accounts Payable?

Gemina Laboratories's Accounts Payable for the quarter that ended in Jan. 2024 was C$1.67 Mil.

Gemina Laboratories's quarterly Accounts Payable increased from Jul. 2023 (C$0.99 Mil) to Oct. 2023 (C$1.30 Mil) and increased from Oct. 2023 (C$1.30 Mil) to Jan. 2024 (C$1.67 Mil).

Gemina Laboratories's annual Accounts Payable increased from Jan. 2022 (C$0.33 Mil) to Jan. 2023 (C$0.93 Mil) and increased from Jan. 2023 (C$0.93 Mil) to Jan. 2024 (C$1.67 Mil).

Gemina Laboratories Accounts Payable Historical Data

The historical data trend for Gemina Laboratories's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Accounts Payable Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Accounts Payable

0.09

0.33

0.93

1.67

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accounts Payable	Get a 7-Day Free Trial							0.93	0.88	0.99	1.30	1.67

Gemina Laboratories Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Gemina Laboratories Accounts Payable Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

GLABF:USA

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines